Search research articles
Contact Us
Filters
Showing results (221-230 of 292) with videos related to
Page
of 30
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2001
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
S Holbert, I Denghien, T Kiechle, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 9, 1997
Diet-induced atherosclerosis in the domestic cat
D G Ginzinger, J E Wilson, D Redenbach, et al.
The Journal of Biological Chemistry
|
January 25, 1992
Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysis
Y H Ma, T Bruin, S Tuzgol, et al.
Clinical Pharmacology and Therapeutics
|
March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers
J Sistonen, P Madadi, C J Ross, et al.
Journal of Molecular and Cellular Cardiology
|
July 1, 1996
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy
S C Tyagi, S G Kumar, S J Haas, et al.
Cell
|
June 2, 1995
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
J Nasir, S B Floresco, J R O'Kusky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia
M E Wittekoek, E Moll, S N Pimstone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene
H Zhang, P W Reymer, M S Liu, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
November 4, 1998
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer
G Liu, K J Excoffon, J E Wilson, et al.
Neurology
|
September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial
B Kremer, C M Clark, E W Almqvist, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 292) with videos related to
Sort By:
Page
of 30
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2001
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis
S Holbert, I Denghien, T Kiechle, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 9, 1997
Diet-induced atherosclerosis in the domestic cat
D G Ginzinger, J E Wilson, D Redenbach, et al.
The Journal of Biological Chemistry
|
January 25, 1992
Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysis
Y H Ma, T Bruin, S Tuzgol, et al.
Clinical Pharmacology and Therapeutics
|
March 9, 2012
Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers
J Sistonen, P Madadi, C J Ross, et al.
Journal of Molecular and Cellular Cardiology
|
July 1, 1996
Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy
S C Tyagi, S G Kumar, S J Haas, et al.
Cell
|
June 2, 1995
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes
J Nasir, S B Floresco, J R O'Kusky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 13, 1999
A frequent mutation in the lipoprotein lipase gene (D9N) deteriorates the biochemical and clinical phenotype of familial hypercholesterolemia
M E Wittekoek, E Moll, S N Pimstone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL gene
H Zhang, P W Reymer, M S Liu, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
November 4, 1998
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer
G Liu, K J Excoffon, J E Wilson, et al.
Neurology
|
September 25, 1999
Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial
B Kremer, C M Clark, E W Almqvist, et al.
Page
of 30